These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 15342212

  • 21. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.
    Gardiner C, Williams K, Longair I, Mackie IJ, Machin SJ, Cohen H.
    Br J Haematol; 2006 Mar; 132(5):598-603. PubMed ID: 16445833
    [Abstract] [Full Text] [Related]

  • 22. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH, Wheeldon NM.
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [Abstract] [Full Text] [Related]

  • 23. Comparison of sampling methods for obtaining accurate coagulation values in hemodialysis patients with heparinized central venous catheters.
    McLaren G, Hanna C, Mills L, Bourdeau J, Cowin R.
    Nephrol Nurs J; 2001 Dec; 28(6):632-6. PubMed ID: 12143472
    [Abstract] [Full Text] [Related]

  • 24. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Dec; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 25. Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic.
    Colella MP, Fiusa MM, Orsi FL, de Paula EV, Annichino-Bizzacchi JM.
    Blood Coagul Fibrinolysis; 2012 Mar; 23(2):172-4. PubMed ID: 22246165
    [Abstract] [Full Text] [Related]

  • 26. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M, Hillarp A, Svensson P.
    Thromb Res; 2004 Mar; 114(2):83-9. PubMed ID: 15306149
    [Abstract] [Full Text] [Related]

  • 27. Admission international normalized ratio and acute infarct volume in ischemic stroke.
    Ay H, Arsava EM, Gungor L, Greer D, Singhal AB, Furie KL, Koroshetz WJ, Sorensen AG.
    Ann Neurol; 2008 Nov; 64(5):499-506. PubMed ID: 18661516
    [Abstract] [Full Text] [Related]

  • 28. INR comparison between the CoaguChek S and a standard laboratory method among patients with self-management of oral anticoagulation.
    Hentrich DP, Fritschi J, Müller PR, Wuillemin WA.
    Thromb Res; 2007 Nov; 119(4):489-95. PubMed ID: 16765423
    [Abstract] [Full Text] [Related]

  • 29. [Advantages of capillary INR monitoring for oral anticoagulation].
    Camp-Wachsmuth M, Humair JP, Boehlen F.
    Rev Med Suisse; 2009 Sep 23; 5(218):1864-7. PubMed ID: 19852415
    [Abstract] [Full Text] [Related]

  • 30. In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation.
    Thompson JL, Sundt TM, Sarano ME, Santrach PJ, Schaff HV.
    Ann Thorac Surg; 2008 Jun 23; 85(6):2046-50. PubMed ID: 18498817
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical impact of point-of-care vs laboratory measurement of anticoagulation.
    Sunderji R, Gin K, Shalansky K, Carter C, Chambers K, Davies C, Schwartz L, Fung A.
    Am J Clin Pathol; 2005 Feb 23; 123(2):184-8. PubMed ID: 15842040
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M, Daniel D, Farrelly B, Coghlan D, Gallus A.
    Thromb Res; 2009 Apr 23; 123(6):909-13. PubMed ID: 19042011
    [Abstract] [Full Text] [Related]

  • 35. Coordinated anticoagulation management in a rural setting.
    Hodge K, Janus E, Sundararajan V, Taylor S, Brand W, Ibrahim JE, Wolff A.
    Aust Fam Physician; 2008 Apr 23; 37(4):280-3. PubMed ID: 18398530
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.
    Harper P, Monahan K, Baker B.
    Intern Med J; 2005 Dec 23; 35(12):717-20. PubMed ID: 16313547
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.